|
JANUARY AND MARCH 2012 FINANCING (Details Textual) (USD $)
|
1 Months Ended |
12 Months Ended |
79 Months Ended |
|
Dec. 31, 2013
|
Jan. 31, 2013
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Dec. 31, 2013
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Exercise Terms and Expiration Description |
|
|
|
In the event that the Companys average daily volume weighted average price was at or above $15.00 during the Measuring Period, the Class B Warrants were to expire unexercised. The Announcement Date was the earlier of (1) the date on which the Company announces via press release the results of the pharmacokinetic study of TNX-102 gelcap; or (2) June 1, 2012. On April 5, 2012 the Company issued a press release announcing the results of the pharmacokinetic study of TNX-102 gelcap, which is defined as an Announcement Date for the purpose of the Class B Warrants. Based on the Companys average daily volume weighted average price of $34.60 per share during the Measuring Period, the Class B Warrants expired unexercised.
|
|
| Change in fair value of warrant liability |
|
|
$ 0
|
$ 1,177,000
|
$ 1,177,000
|
| Warrants Issued During Period To Purchase Common Stock |
3,185
|
10,800
|
|
|
|
| Stock Units Issued Upon Conversion Of Convertible Debt Purchase Price |
|
|
|
25,000
|
|
| Warrants reclassified to equity upon expiry of reset provisions |
|
|
0
|
3,939,000
|
3,939,000
|
| Warrants Exercise Price (in dollars per share) |
$ 4.25
|
$ 12.00
|
$ 8
|
|
|
|
Common Stock [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Number Of Shares Included In One Stock Unit (in shares) |
|
|
|
1,250
|
|
|
Warrant [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Valuation Assumptions Issuance Date 1 |
|
|
|
Jan. 20,
2012
|
|
| Valuation Assumptions Issuance Date 2 |
|
|
|
Mar.
01,
2012
|
|
| Valuation Assumptions Expiration Date |
|
|
|
Jun.
06,
2012
|
|
|
Additional Paid-In Capital [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants reclassified to equity upon expiry of reset provisions |
|
|
|
3,938,946
|
|
|
Placement Agents [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
1,538
|
|
| Financing Arrangements Expense |
|
|
|
706,511
|
|
| Warrants Exercise Price (in dollars per share) |
|
|
|
$ 20.00
|
|
|
Placement Agents [Member] | Other Financing Cost [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Financing Arrangements Expense |
|
|
|
270,798
|
|
|
Placement Agents [Member] | Additional Paid-In Capital [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Financing Arrangements Expense |
|
|
|
435,713
|
|
|
Minimum [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Percentage Of Investor Fee Payable Under Registration Rights Agreement |
|
|
|
1.00%
|
|
|
Maximum [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Percentage Of Investor Fee Payable Under Registration Rights Agreement |
|
|
|
10.00%
|
|
|
Class A Warrant [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued (in shares) |
|
|
|
1,250
|
|
|
Class B Warrant [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued (in shares) |
|
|
|
1,250
|
|
| Entity Minimum Volume Weighted Average Price Effect On Exercise Warrants |
|
|
|
$ 15.00
|
|
|
January 2012 Financing [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Stock Units Issued During Period |
|
|
|
172.118
|
|
| Proceeds From Issuance Of Stock Units |
|
|
|
2,377,950
|
|
| Proceeds From Conversion Of Convertible Debentures |
|
|
|
1,925,000
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
215,148
|
|
| Repayments of Debt |
|
|
|
150,000
|
|
| Stock Issued During Period, Shares, Other |
|
|
|
29,700
|
|
| Stock Issued During Period, Value, Other |
|
|
|
368,280
|
|
|
January 2012 Financing [Member] | Debenture Warrant [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
13,750
|
|
| Warrants Exercise Price (in dollars per share) |
|
|
|
$ 20.00
|
|
| Warrant, Term |
|
|
|
3 years
|
|
| Warrants, Fair Value |
|
|
|
83,289
|
|
|
January 2012 Financing [Member] | Placement Agents [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
11,765
|
|
|
March 2012 Financing [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Stock Units Issued During Period |
|
|
|
92.5926
|
|
| Proceeds From Issuance Of Stock Units |
|
|
|
2,314,815
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
115,741
|
|
|
March 2012 Financing [Member] | Placement Agents [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
11,575
|
|
|
Financing Arrangements [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Percentage Of Shares Issuable Upon Exercise Of Warrants |
|
|
|
10.00%
|
|
| Warrants Exercise Price (in dollars per share) |
|
|
|
$ 25.00
|
|
|
Financing Arrangements [Member] | Placement Agents [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Payment For Commission |
|
|
|
466,777
|
|
| Percentage Of Commission Paid |
|
|
|
8.00%
|
|
| Percentage Of Non Accountable Expenses |
|
|
|
2.00%
|
|
| Warrants Issued During Period To Purchase Common Stock |
|
|
|
23,339
|
|
| Warrants Exercise Price (in dollars per share) |
|
|
|
$ 25.00
|
|
|
Financing Arrangements [Member] | Class A Warrant [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Not Settleable In Cash Fair Value Disclosure |
|
|
|
2,549,684
|
|
|
Financing Arrangements [Member] | Agent Warrants [Member]
|
|
|
|
|
|
| Securities Financing Transaction [Line Items] |
|
|
|
|
|
| Warrants Not Settleable In Cash Fair Value Disclosure |
|
|
|
$ 212,235
|
|